Cargando…
Validation and refinement of a RUNX1 mutation-associated gene expression signature in blast crisis chronic myeloid leukemia
Autores principales: | Lee, Kian Leong, Ko, Tun Kiat, Saw, Nicole Y. L., Javed, Asif, Hillmer, Axel M., Chuah, Charles, Krishnan, Vaidehi, Ong, S. Tiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885404/ https://www.ncbi.nlm.nih.gov/pubmed/35121847 http://dx.doi.org/10.1038/s41375-022-01508-1 |
Ejemplares similares
-
The HDAC inhibitor SB939 overcomes resistance to BCR-ABL kinase Inhibitors conferred by the BIM deletion polymorphism in chronic myeloid leukemia
por: Rauzan, Muhammad, et al.
Publicado: (2017) -
The BCL2 inhibitor ABT-199 significantly enhances imatinib-induced cell death in chronic myeloid leukemia progenitors
por: Ko, Tun Kiat, et al.
Publicado: (2014) -
Pediatric chronic myeloid leukemia in myeloid blast crisis
por: Dey, Biswajit, et al.
Publicado: (2023) -
The RUNX Family of Proteins, DNA Repair, and Cancer
por: Krishnan, Vaidehi
Publicado: (2023) -
Acquired Factor VII Deficiency Associated With Chronic Myeloid Leukemia Blast Crisis
por: Wolf, Emily B., et al.
Publicado: (2023)